Fundraising FoxCDP Venture Capital — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)inPietro Faccioli(Co-founder)inGiovanni Spagnolli(Co-founder, CTO)inMaria Letizia Barreca(Co-founder)inGraziano Lolli(Co-founder)
Co-investors3B Future Health FundSeroba Life SciencesV-Bio VenturesVI PartnersVertis SGRClaris Ventures+1 more
Empatica offers an FDA-cleared health monitoring platform combining medical wearables and digital biomarkers to collect continuous, clinical-quality health data from daily life.
AI & Machine LearningDigital HealthHealthtechMedical DevicesCambridge, US
Rosalind Picard(Founder)inMatteo Lai(Executive Officer, Director)inSimone Tognetti(Director)inLen Picard(Executive Officer, Director)inMario Scuderi(Director)
Co-investorsBlack Opal VenturesRA CapitalSanofi VenturesInnogest Capital
Gyala offers an Italian-developed cybersecurity platform that protects IT, OT, and IoT infrastructure, using military-derived AI to detect behavioral anomalies and trigger automated, customizable responses at the endpoint level in real time, 24/7.
AI & Machine LearningCybersecurityIoT
Nicola Mugnato(CTO & Founder)inGian Roberto Sfoglietta(CEO & Founder)inAndrea Storico(Chairman & Founder)
Co-investorsDeep Ocean Capital SGR S.P.A.Italian Angels for Growth
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.